QUOTE AND NEWS
Market Intelligence Center  May 16  Comment 
HCA Holdings Inc. (NYSE: HCA) closed Wednesday's trading session at $40.20. In the past year, the stock has hit a 52-week low of $23.91 and 52-week high of $41.83. HCA (HCA) stock has been showing support around $39.28 and resistance in the $41.08...
Benzinga  May 13  Comment 
In a report published Monday, BMO Capital Markets analyst Jennifer Lynch reiterated a Market Perform rating on HCA Holdings (NYSE: HCA), and slightly raised the price target from $42.00 to $43.00. In the report, Lynch noted, “While HCA volume...
Benzinga  May 9  Comment 
HCA Holdings, Inc. (NYSE: HCA) today announced that Ann Huntress Lamont, Managing Partner of Oak Investment Partners, has been named an independent director of HCA's board, effective immediately. With her addition, HCA's board of directors...
Benzinga  May 3  Comment 
In a report published Friday, Credit Suisse analyst Ralph Giacobbe reiterated an Outperform rating on HCA Holdings (NYSE: HCA), and raised the price target from $41.00 to $47.00. In the report, Giacobbe noted, “HCA reported 1Q13 adjusted EPS...
Market Intelligence Center  May 3  Comment 
HCA Holdings Inc. (NYSE: HCA) closed Thursday's trading session at $40.47. In the past year, the stock has hit a 52-week low of $23.91 and 52-week high of $41.83. HCA (HCA) stock has been showing support around $37.61 and resistance in the $42.37...
Benzinga  May 1  Comment 
With pen to paper, and after almost two and a half months of negotiations, MGM Resorts International (NYSE: MGM) and the City of Springfield today marked the signing of a Host Community Agreement ("HCA") that incorporates more than $25 million in...
StreetInsider.com  Apr 29  Comment 
This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High: HCA Holdings, Inc. (NYSE: HCA) $41.83. HCA and other hospital stocks moving higher on a new U.S. government...
Benzinga  Apr 16  Comment 
Sarepta Therapeutics (NASDAQ: SRPT) dipped 7.42% to $36.33 in the pre-market session. Leerink downgraded Sarepta from “outperform” to “market perform.” HCA Holdings (NYSE: HCA) shares dropped 3.05% to $35.60 in pre-market trading. HCA...




 
TOP CONTRIBUTORS

HCA Holdings (NYSE:HCA) is a non-governmental hospital operator. HCA operates 164 hospitals spread across 20 states in the US and in England. This corresponds to approximately 41,000 beds and 106 freestanding surgery centers. The holding company focuses on developing its reach in urban and growing demographics. In terms of hospitals under operation, HCA is the largest non-government operator in the United States.[1]

HCA expects overall demand for its services to rise. The US Census Bureau predicts thats the number of persons in the US over the age of 65 will increase by a Compounded annual growth rate - CAGR of 3% over the next 20 years. This means that it will correspond to roughly 19.3% of the US population by 2030. The rise in this age group will increase demand for healthcare services and medical procedures. Furthermore, the Health Reform Law which was signed into law by President Obama in 2010 expands healthcare coverage to uninsured Americans. This significant rise will further drive the demand for healthcare related services.[2]

The company's initial public offering of stock on the NYSE occurred on March9, 2011. The company offered 126.2M shares each for $30. This was at the high end of the $27-$30 range. The company also sold 2.2M more shares than the 124M that was originally planned. This brought the total deal size to $3.8B, making it the largest Private Equity backed IPO on a US exchange. The lead underwriters of the IPO were BofA, Citi, and J P Morgan Chase (JPM).[3]

HCA reported a total revenue for 2010 of $30.7B. This was a slight increase from the 2009 total revenue of $30.1B. The company increased its net income to $1.21B, over the $1.05B announced in 2009.[4]

References

  1. HCA S-1/A 2011 PROSPECTUS SUMMARY "Our Company" pg 1
  2. HCA S-1/A 2011 PROSPECTUS SUMMARY "Our Industry" pg 2
  3. Renaissance Capital - IPO Home "HCA Holdings prices IPO at $30.00, high end of the range" 19 March 2011
  4. HCA S-1/A 2011 PROSPECTUS SUMMARY "Our Company" pg 9
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki